CIK 0001736243 · <br>Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-06 | DELUCCIA ROBERT J Director | Purchase · Warrants for Common Stock | +49,261 | 49,261 | ||
| 2025-01-06 | DEAN JACK H Director | Purchase | +9,852 | $1.02 | $10K | 21,776 |
| 2025-01-06 | DEAN JACK H Director | Purchase · Warrants for Common Stock | +9,852 | 9,852 | ||
| 2024-06-17 | Scodari Joseph C Director | Grant or award · Stock Option | +12,000 | 12,000 | ||
| 2024-06-17 | Sailer Carl Director | Grant or award · Stock Option | +12,000 | 12,000 | ||
| 2024-06-17 | HARRISON THOMAS L Director | Grant or award · Stock Option | +12,000 | 12,000 | ||
| 2024-06-17 | Donohue James J. Director | Grant or award · Stock Option | +12,000 | 12,000 | ||
| 2024-06-17 | DEAN JACK H Director | Grant or award · Stock Option | +12,000 | 12,000 | ||
| 2024-02-23 | LUCI DAVID P President and CEO | Grant or award · Stock Option | +250,000 | 250,000 | ||
| 2024-02-23 | Shawah Robert G. Chief Financial Officer | Grant or award · Stock Option | +145,000 | 145,000 | ||
| 2024-02-23 | DELUCCIA ROBERT J Director | Grant or award · Stock Option | +250,000 | 250,000 | ||
| 2024-01-19 | Sailer Carl Director | Option exercise | +19,737 | $3.55 | $70K | 112,552 |
| 2024-01-19 | Sailer Carl Director | Option exercise · Warrants for Common Stock | −19,737 | 0 | ||
| 2024-01-03 | DELUCCIA ROBERT J Director | Option exercise | +19,737 | $3.55 | $70K | 960,935 |
| 2024-01-03 | DELUCCIA ROBERT J Director | Option exercise · Warrants for Common Stock | −19,737 | 0 | ||
| 2024-01-03 | LUCI DAVID P President and CEO | Option exercise | +19,737 | $3.55 | $70K | 1,048,197 |
| 2024-01-03 | LUCI DAVID P President and CEO | Option exercise · Warrants for Common Stock | −19,737 | 0 | ||
| 2023-12-22 | DELUCCIA ROBERT J Director | Gift | −30,000 | 941,198 | ||
| 2023-12-12 | DELUCCIA ROBERT J Director | Gift | −40,000 | 971,198 | ||
| 2023-06-15 | Donohue James J. Director | Grant or award · Stock Option | +10,000 | 10,000 |
Page 2 of 4 · 72 trades